Amphotericin B Related Published Studies
Well-designed clinical trials related to Amphotericin B
Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden. [2011.07]
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. [2011.06.30]
Single-dose liposomal amphotericin B (AmBisome(R)) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. [2011.03.06]
Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study. [2011.01]
Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients. [2010.12.15]
Improving outcome of treatment of kala-azar by supplementation of amphotericin B with physiologic saline and potassium chloride. [2010.11]
Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients. [2010.10]
Amphotericin B therapy in children with visceral leishmaniasis: daily vs. alternate day, a randomized trial. [2010.10]
Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis. [2010.09]
Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. [2010.07.15]
Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis. [2010.06]
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. [2010.05]
Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study. [2010.04.12]
Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial. [2010.04]
Single-dose liposomal amphotericin B for visceral leishmaniasis in India. [2010.02.11]
Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study. [2010.02]
Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B. [2010.01]
Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B
deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a
randomized, double-blind clinical trial of efficacy and safety. [2010]
A randomized, double-blind, multicenter study of caspofungin versus liposomal
amphotericin B for empiric antifungal therapy in pediatric patients with
persistent fever and neutropenia. [2010]
A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever. [2009.11]
Pharmacokinetics and buccal mucosal concentrations of a 15 milligram per kilogram of body weight total dose of liposomal amphotericin B administered as a single dose (15 mg/kg), weekly dose (7.5 mg/kg), or daily dose (1 mg/kg) in peripheral stem cell transplant patients. [2009.09]
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. [2009.06.15]
Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia. [2009.06]
Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. [2009.06]
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. [2009.04]
The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. [2009.02]
A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India. [2009.02]
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia. [2009.01]
Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. [2009]
Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B. [2009]
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after Allo-SCT. [2008.12.15]
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial. [2008.12]
Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. [2008.10.25]
New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. [2008.10.15]
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: Data from a randomized placebo-controlled trial. [2008.10.07]
[Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis. Can recidive polyposis be prevented?] [2008.09.14]
Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. [2008.09]
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. [2008.07.01]
Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals. [2008.06]
Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. [2008.05.01]
[Impact on renal function of an early switch from conventional to liposomal amphotericin B formulation in the empirical treatment of fungal infections] [2008.04]
Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting. [2008.04]
Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals. [2008.01.14]
IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. [2007.10.15]
Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions. [2007.09.01]
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis. [2007.09]
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis. [2007.07.01]
A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK. [2007.06]
Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial. [2007.05.09]
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. [2007.05.05]
Poor efficacy of amphotericin B-based therapy in CNS aspergillosis. [2007.05]
Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial. [2007]
Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. [2006.11]
Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial. [2006.08]
A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. [2006.05.15]
Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis. [2006.03.01]
Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection. [2006]
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. [2005.11.15]
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. [2005.10.22]
Low-dose amphotericin for prevention of serious fungal infection following liver transplantation. [2005.09]
Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. [2005.01]
Well-designed clinical trials possibly related to Amphotericin B
Does oral sodium bicarbonate therapy improve function and quality of life in
older patients with chronic kidney disease and low-grade acidosis (the BiCARB
trial)? Study protocol for a randomized controlled trial. [2015]
Closeout of the HALT-PKD trials. [2015]
Pravastatin Therapy and Biomarker Changes in Children and Young Adults with
Autosomal Dominant Polycystic Kidney Disease. [2015]
Muco-bioadhesive containing ginger officinal e extract in the management of
recurrent aphthous stomatitis: A randomized clinical study. [2015]
Add-on Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative
and Anxiety Symptoms of Schizophrenia: An 8-week, randomized, double-blind,
placebo-controlled trial. [2015]
Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection. [2015]
Probiotics for Clostridium difficile infection in adults (PICO): Study protocol
for a double-blind, randomized controlled trial. [2015]
Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using
a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial. [2015]
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone
Agonist for Endometriosis: A Randomized Controlled Trial. [2015]
Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute
myocardial infarction: double-blind, randomized controlled trial. [2015]
Effects of Vitamin K on Matrix Metalloproteinase-3 and Rheumatoid Factor in Women
with Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Trial. [2015]
Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following
Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized
Clinical Trial. [2015]
The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk
in O blood group Helicobacter pylori-infected patients: a randomized double-blind
clinical trial. [2015]
Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a
Large Double-blind Clinical Trial of Chemotherapy for Breast Cancer. [2015]
A comparative study between the efficacy of oral cimetidine and low-dose systemic
meglumine antimoniate (MA) with a standard dose of systemic MA in the treatment
of cutaneous leishmaniasis. [2015]
Huo-Luo-Xiao-Ling (HLXL)-Dan, a Traditional Chinese Medicine, for patients with
osteoarthritis of the knee: a multi-site, randomized, double-blind,
placebo-controlled phase II clinical trial. [2015]
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. [2015]
Safety and immunogenicity of a single intramuscular dose of a tetanus- diphtheria
toxoid (Td) vaccine (BR-TD-1001) in healthy Korean adult subjects. [2015]
High-cocoa polyphenol-rich chocolate improves blood pressure in patients with
diabetes and hypertension. [2015]
TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study
protocol for a randomized controlled trial. [2015]
A proprietary herbal medicine (5-Ling Granule) for Tourette syndrome: a
randomized controlled trial. [2015]
Efficacy of Benzocaine 20% Topical Anesthetic Compared to Placebo Prior to
Administration of Local Anesthesia in the Oral Cavity: A Randomized Controlled
Trial. [2015]
Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on
Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled
One-Year Intervention Trial (the SAFIR Study). [2015]
Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk
factors in obese women: a randomized controlled clinical trial. [2015]
Preventive study in subjects at risk of fatal familial insomnia: Innovative
approach to rare diseases. [2015]
Zinc sulphate: A reasonable choice for depression management in patients with
multiple sclerosis: A randomized, double-blind, placebo-controlled clinical
trial. [2015]
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated
urinary-tract infections, including pyelonephritis: a randomised, double-blind,
phase 3 trial (ASPECT-cUTI). [2015]
Effects of traditional Chinese medicine Shu Gan Jian Pi granules on patients with
breast cancer and cancer-related fatigue: study protocol for a randomized
controlled trial. [2015]
Single dose oral ibuprofen plus codeine for acute postoperative pain in adults. [2015]
Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in
Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a
randomized controlled trial. [2015]
The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for
treating Alzheimer's disease: protocol for a randomized controlled trial. [2015]
Acupuncture to Reduce HIV-Associated Inflammation. [2015]
Testosterone replacement therapy in older male subjective memory complainers:
double-blind randomized crossover placebo-controlled clinical trial of
physiological assessment and safety. [2015]
A Prospective, Split-Face, Randomized, Double-Blind Study Comparing
OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles. [2015]
Short-term blood pressure variability in acute stroke: post hoc analysis of the
controlling hypertension and hypotension immediately post stroke and continue or
stop post-stroke antihypertensives collaborative study trials. [2015]
Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile
in type 2 diabetic patients: a randomized double-blind placebo-controlled
clinical trial. [2015]
The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1
Trial. [2015]
Efficacy and safety of sublingual immunotherapy for two seasons in patients with
Japanese cedar pollinosis. [2015]
Treatment efficacy of sacral nerve stimulation in slow transit constipation: a
two-phase, double-blind randomized controlled crossover study. [2015]
Comparison of two hyaluronic acid formulations for safety and efficacy (CHASE)
study in knee osteoarthritis: a multicenter, randomized, double-blind, 26-week
non-inferiority trial comparing Durolane to Artz. [2015]
|
